Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals.
Menown
I B
IB
Adgey
A A
AA
D015906:Angioplasty, Balloon, Coronary; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017209:Apoptosis; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D019194:Ischemic Preconditioning; D009203:Myocardial Infarction / Q000188:drug therapy*; D015425:Myocardial Reperfusion / Q000379:methods; D015427:Reperfusion Injury / Q000517:prevention & control*; D017923:Sodium-Hydrogen Exchangers / Q000037:antagonists & inhibitors*; D013450:Sulfones / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
D000889:Anti-Arrhythmia Agents; D006146:Guanidines; D017923:Sodium-Hydrogen Exchangers; D013450:Sulfones; C069139:growth factor-activatable Na-H exchanger NHE-1; C093373:cariporide; C118397:eniporide